Research Division, Institute of Mental Health, Buangkok Green Medical Park, 10 Buangkok View, Singapore 539747, Singapore.
BMC Psychiatry. 2013 Sep 23;13:231. doi: 10.1186/1471-244X-13-231.
Prescription and use of antidepressants and benzodiazepines are common in the general population. Prescription of psychotropic drugs is a complex process: patient, physician and healthcare characteristics mediate, interact and influence it. The current study aimed to establish the prevalence and factors associated with the use of antidepressants (ADs) and benzodiazepines (BZDs) in Singapore.
The Singapore Mental Health Study (SMHS) was a nationally representative survey of Singapore Residents aged 18 years and above. Face-to-face interviews were conducted from December 2009 to December 2010. The diagnoses of mental disorders were established using the Composite International Diagnostic Interview version 3.0 (CIDI-3.0). The pharmacoepidemiology section was used to collect information on medication use.
The overall prevalence estimates for ADs and BZDs use during the 12 months prior to the interview were 1.1% and 1.2% respectively. In all, 2.0% had used ADs and/or BZDs. 'Help seeking for emotional or mental health problems' was the most important predictor for the use of ADs and BZDs-help seekers were much more likely to use ADs (adjusted OR: 31.62, 95% CI: 13.36-74.83) and more likely to use BZDs than non--help seekers in the previous 12 months (adjusted OR: 34.38, 95% CI: 12.97-91.16). Only 27.6% of those with 12-month major depressive disorder (MDD) had sought formal medical help for their problems and ADs were being used by just over a quarter of this 'help-seeking group' (26.3%).
We found that the use of ADs and BZDs in our population was relatively low, and 'help-seeking' was the most important predictor of the use of ADs and BZDs. In concordance with research from other Western countries, use of ADs was low among those with 12-month MDD.
抗抑郁药和苯二氮䓬类药物的处方和使用在普通人群中很常见。精神药物的处方是一个复杂的过程:患者、医生和医疗保健特征介导、相互作用和影响它。本研究旨在确定新加坡使用抗抑郁药(ADs)和苯二氮䓬类药物(BZDs)的流行率和相关因素。
新加坡心理健康研究(SMHS)是一项对年龄在 18 岁及以上的新加坡居民进行的全国代表性调查。从 2009 年 12 月至 2010 年 12 月进行面对面访谈。使用复合国际诊断访谈第 3.0 版(CIDI-3.0)建立精神障碍诊断。药物流行病学部分用于收集用药信息。
在接受采访前 12 个月内,ADs 和 BZDs 的总体使用估计率分别为 1.1%和 1.2%。总共有 2.0%的人使用了 ADs 和/或 BZDs。“寻求情感或心理健康问题的帮助”是使用 ADs 和 BZDs 的最重要预测因素——寻求帮助者更有可能使用 ADs(调整后的 OR:31.62,95%CI:13.36-74.83),并且在过去 12 个月中更有可能比非求助者使用 BZDs(调整后的 OR:34.38,95%CI:12.97-91.16)。在 12 个月的重度抑郁症(MDD)患者中,只有 27.6%的人因自身问题寻求过正规医疗帮助,而在这个“寻求帮助的群体”中,只有略多于四分之一(26.3%)的人使用了 ADs。
我们发现,我们人群中 ADs 和 BZDs 的使用相对较低,“寻求帮助”是使用 ADs 和 BZDs 的最重要预测因素。与其他西方国家的研究一致,12 个月 MDD 患者使用 ADs 的比例较低。